There are currently 276 active clinical trials seeking participants for Cancer research studies. The states with the highest number of trials for Cancer participants are California, Texas, New York and Florida.
Virtual Reality Therapy for Cancer-Treatment Associated Symptoms
NCT06248216
Recruiting
We propose an innovative approach to symptom management in cancer patients following cancer treatments, utilizing a Multimodal Integrative Therapy (MIT) delivered via Virtual Reality (VR) program, authorized by the US Food and Drug Administration for in-home use. Our primary goal is to generate pilot data on the effects of MIT-VR program on pain, fatigue, sleep, depression, and anxiety in participants suffering from chronic cancer symptoms following cancer treatments.
Gender:
ALL
Ages:
Between 18 years and 88 years
Trial Updated:
12/04/2024
Locations: Luana Colloca, Baltimore, Maryland +1 locations
Conditions: Cancer, Cancer Pain, Virtual Reality
Register for Updates
Improving Outcomes for Older Adults Undergoing Radiation Therapy
NCT05721053
Recruiting
The purpose of this study is to improve healthcare received by people ≥ 65 years who are receiving radiation therapy (RT). The study will primarily examine patients ability to complete RT, changes in a patients' daily function and self-reported toxicities. To collect this information, study participants will be asked to complete surveys and physical and cognitive function assessments at five different timepoints in their treatment: before RT, End of RT, and at 1, 3, and 6 months follow up visits... Read More
Gender:
ALL
Ages:
65 years and above
Trial Updated:
12/03/2024
Locations: One Gustave L Levy Place, New York, New York
Conditions: Cancer, Radiation Therapy
Register for Updates
The Gut Microbiome and Immunotherapy Response in Solid Cancers
NCT06050733
Recruiting
The aim of this study is characterize the gastrointestinal microbiomes of patient with solid cancer undergoing standard of care treatment with programmed cell death protein 1 (PD-1) /programmed cell death ligand (PD-L1) blockade.
Gender:
ALL
Ages:
Between 35 years and 75 years
Trial Updated:
12/03/2024
Locations: University of Texas Medical Branch, Galveston, Texas
Conditions: Cancer
Register for Updates
A Digital Art Activity to Enhance Self-Disclosure and the Detection of Psycho-social Distress in Adult Cancer Patients
NCT06127121
Recruiting
To look at how a digital art activity may help cancer patients improve their ability to express their distress, symptoms, and lived experience.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
11/25/2024
Locations: MD Anderson Cancer Center, Houston, Texas
Conditions: Cancer
Register for Updates
ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors
NCT03686124
Recruiting
The study purpose is to establish the safety and tolerability of IMA203/IMA203CD8 products with or without combination with nivolumab in patients with solid tumors that express preferentially expressed antigen in melanoma (PRAME).
Gender:
ALL
Ages:
18 years and above
Trial Updated:
11/22/2024
Locations: University of Miami Hospital and Clinics, Miami, Florida +11 locations
Conditions: Refractory Cancer, Recurrent Cancer, Solid Tumor, Adult, Cancer
Register for Updates
Impact of the Coronavirus (COVID-19) on Patients With Cancer
NCT04330521
Recruiting
The purpose of this study is to understand the impact of COVID-19 on patients with cancer through a survey.
Gender:
ALL
Ages:
Between 18 years and 99 years
Trial Updated:
11/20/2024
Locations: Stanford University School of Medicine, Stanford, California
Conditions: Cancer, COVID-19
Register for Updates
Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With Cancer
NCT01542879
Recruiting
A research study on the diagnosis of spread of disease for children who have been diagnosed with solid tumors using a new whole body imaging technique and a new MR contrast agent (ferumoxytol). Standard tests that are used to determine the extent and possible spread of a child's disease include magnetic resonance (MR) imaging, computed tomography (CT), Positron Emission Tomography (PET) as well as bone scanning, and metaiodobenzylguanidine (MIBG) scanning. The purpose of this study is to determi... Read More
Gender:
ALL
Ages:
Between 6 years and 40 years
Trial Updated:
11/20/2024
Locations: Stanford University Cancer Institute, Stanford, California
Conditions: Cancer
Register for Updates
A Novel Intervention for Patients With Cancer
NCT05643027
Recruiting
This research study is being done to develop an intervention for psychological symptoms that patients diagnosed with cancer may experience. Psychological symptoms may include thoughts, feelings, emotions, and memories The names of the study intervention and research activities involved in this study are/is: * Acceptance \& Commitment Therapy (ACT) for Cancer (involving 6 sessions with a licensed clinical psychologist) * Questionnaires * Post-study interview Consistent with the NIH Stage Model... Read More
Gender:
ALL
Ages:
Between 18 years and 99 years
Trial Updated:
11/20/2024
Locations: Dana Farber Cancer Institute, Boston, Massachusetts
Conditions: Substance Use, Cancer, Psychological
Register for Updates
Abatacept in Immune Checkpoint Inhibitor Myocarditis
NCT05335928
Recruiting
The primary aim is to test whether abatacept, as compared to placebo, is associated with a reduction in major adverse cardiac events (MACE) among participants hospitalized with myocarditis secondary to an immune checkpoint inhibitor (ICI). The primary outcome, MACE, is a composite of first occurrence of cardiovascular death, non-fatal sudden cardiac arrest, cardiogenic shock, significant ventricular arrythmias, significant bradyarrythmias, or incident heart failure.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
11/19/2024
Locations: Cedars-Sinai Medical Center, Los Angeles, California +30 locations
Conditions: Myocarditis Acute, Cancer
Register for Updates
Combination Therapy for Treatment of Sleep Disturbance in Patients With Advanced Cancer
NCT05474846
Recruiting
To learn if Cognitive Behavior Therapy (called CBT), combined with either Bright Light Therapy (called BLT), methylphenidate, and/or melatonin, can help improve sleep and other related symptoms such as fatigue, anxiety, and depression in cancer patients. This is an investigational study. In this study, BLT, Methylphenidate and Melatonin will be compared to their placebos.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
11/18/2024
Locations: MD Anderson Cancer Center, Houston, Texas
Conditions: Sleep, Fatigue, Anxiety, Cancer, Depression
Register for Updates
Cryopreservation of Ovarian Tissue
NCT01558544
Recruiting
The study hopes to contribute to the development of technologies of ovarian tissue freezing-thawing and in vitro maturation of immature eggs such that a person at risk for premature ovarian failure might be able to conceive a genetically related child.
Gender:
FEMALE
Ages:
45 years and below
Trial Updated:
11/15/2024
Locations: Ronald O. Perelman and Claudia Cohen Center for Reproductive Medicine, New York, New York
Conditions: Cancer, Risk of Premature Ovarian Failure, Fertility Preservation
Register for Updates
Correlation Vitamin D Level to Endocrine Autoimmune Toxicity Due to Immune Checkpoint Inhibitors
NCT04615988
Recruiting
The purpose of this research study is to see if the amount of vitamin D in ones blood makes it more or less likely to develop thyroid gland toxicity when being treated with immunotherapy that blocks the activity of proteins called programed death-1(PD-1) or programmed death ligand-1 (PD-L1). Immunotherapy is treatment that makes changes to the immune system to try to fight cancer. Immunotherapy treatments that block the activity of important parts of the immune system called PD-1 and PD-L1 are u... Read More
Gender:
ALL
Ages:
18 years and above
Trial Updated:
11/14/2024
Locations: Mount Sinai Hospital /Tisch Cancer Cancer/Ruttenberg Treatment Center, New York, New York
Conditions: Thyroid, PD-1, Cancer
Register for Updates